Your browser doesn't support javascript.
loading
Evaluation of the prognostic and predictive value of HER-1/EGFR in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Tzaida, Olympia; Gogas, Helen; Dafni, Urania; Kyroudi, Aspasia; Papaspyrou, Irene; Kyriakou, Vasiliki; Malamou-Mitsi, Vasiliki; Alamani, Maria; Skopa, Chrisoula; Kostopoulos, Ioannis; Kastritis, Efstathios; Pectasides, Dimitrios; Briasoulis, Evangelos; Kalofonos, Haralabos P; Aravantinos, Gerasimos; Fountzilas, George; Arapantoni-Dadioti, Petroula.
Affiliation
  • Tzaida O; Metaxas Cancer Hospital, Piraeus, Greece.
Oncology ; 72(5-6): 388-96, 2007.
Article in En | MEDLINE | ID: mdl-18187961
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Epirubicin / Antineoplastic Combined Chemotherapy Protocols / Paclitaxel / Genes, erbB-1 Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Oncology Year: 2007 Type: Article Affiliation country: Greece
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Epirubicin / Antineoplastic Combined Chemotherapy Protocols / Paclitaxel / Genes, erbB-1 Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Oncology Year: 2007 Type: Article Affiliation country: Greece